Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Viral infections and antiphospholipid antibodies

Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 302

Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells

Azizi, S. A., & Azizi, S. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00903-7 · Cited by 48

Adaptive Immunity and the Risk of Autoreactivity in COVID-19

Moody, R., Wilson, K., Flanagan, K. L., Jaworowski, A., & Plebanski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168965 · Cited by 49

Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients

Genchi, A., Semerano, A., Schwarz, G., Dell’Acqua, B., Gullotta, G. S., Sampaolo, M., Boeri, E., Quattrini, A., Sanvito, F., Diamanti, S., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01313-y · Cited by 46

Altered platelet and coagulation function in moderate-to-severe COVID-19

Игоревич, Л. Р., Evtugina, N. G., Peshkova, A. D., Safiullina, S. I., Andrianova, I. A., Khabirova, A. I., Nagaswami, C., Рафикович, Х. Р., Sannikova, S. S., & Weisel, J. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-95397-6 · Cited by 46

COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm

Fujimura, Y., & Holland, L. Z. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03324-w · Cited by 43

Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities

Chavda, V. K., Chaurasia, B. K., Fiorindi, A., Umana, G. E., Lu, B., & Montemurro, N. (2022) · Neurology International · doi:10.3390/neurolint14020032 · Cited by 49

In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective

Rahman, M. M., Islam, M. R., Akash, S., Mim, S. A., Rahaman, M. S., Emran, T. B., Akkol, E. K., Sharma, R., Alhumaydhi, F. A., Sweilam, S. H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.929430 · Cited by 49

Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series

Tabatabai, A., Rabin, J., Menaker, J. A., Madathil, R. J., Galvagno, S. M., Menne, A. R., Chow, J. H., Grazioli, A., Herr, D., Tanaka, K. A., et al. (2020) · A&A Practice · doi:10.1213/xaa.0000000000001236 · Cited by 45

COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review

Sherren, P. B., Ostermann, M., Agarwal, S., Meadows, C. I. S., Ioannou, N., & Camporota, L. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.08.050 · Cited by 45

Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic

Rana, A. K., Rahmatkar, S. N., Kumar, A., & Singh, D. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.08.002 · Cited by 48

Stroke Care during the COVID-19 Pandemic: International Expert Panel Review

Venketasubramanian, N., Anderson, C. S., Ay, H., Aybek, S., Brinjikji, W., de Freitas, G. R., Brutto, Ó. H. D., Fassbender, K. C., Fujimura, M., Goldstein, L. B., et al. (2021) · Cerebrovascular Diseases · doi:10.1159/000514155 · Cited by 49

Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study

See, Y. P., Young, B. E., Ang, L. W., Ooi, X. Y., Chan, C. P., Looi, W. L., Yeo, S. C., & Lye, D. C. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000514064 · Cited by 46

A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection

O’Loughlin, L., Toledo, N. A., Budrie, L., Waechter, R. L., & Rayner, J. C. (2021) · Neurology International · doi:10.3390/neurolint13030041 · Cited by 45

COVID-19: systemic pathology and its implications for therapy

Shen, Q., Li, J., Zhang, Z., Guo, S., Wang, Q., An, X., & Chang, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.65911 · Cited by 51

COVID ‐19 and plasma cells: Is there long‐lived protection?*

Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 48

C1 esterase inhibitor and the contact system in COVID‐19

Thomson, T. M., Toscano, E., Casís, E., & Paciucci, R. (2020) · British Journal of Haematology · doi:10.1111/bjh.16938 · Cited by 45

Immunological and physiopathological approach of COVID-19 in pregnancy

Ferrer‐Oliveras, R., Mendoza, M., Capote, S., Pratcorona, L., Esteve‐Valverde, E., Cabero, L., & Alijotas‐Reig, J. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06061-3 · Cited by 46

Activation of ang-(1-7)/mas receptor is a possible strategy to treat coronavirus (SARS-CoV-2) infection

Magalhaes, G. S., Rodrigues-Machado, M. D. G., Motta-Santos, D., Campagnole-Santos, M. J., & Santos, R. A. S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00730 · Cited by 44

Encephalopathy in COVID-19 patients; viral, parainfectious, or both?

Umapathi, T., Quek, W. M. J., Yen, J. M., Khin, H. S. W., Mah, Y. Y., Chan, C. Y. J., Ling, L. M., & Yu, W. (2020) · eNeurologicalSci · doi:10.1016/j.ensci.2020.100275 · Cited by 45

SARS-CoV-2 infection and thrombotic complications: a narrative review

Moschonas, I. C., & Tselepis, A. D. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02374-3 · Cited by 45

Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms

González, F., Correa, C. I. C., & Peñaranda, E. (2021) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2021.01.024 · Cited by 43

Covid‐19 pandemic and the skin

Drenovska, K., Schmidt, E., & Vassileva, S. (2020) · International Journal of Dermatology · doi:10.1111/ijd.15189 · Cited by 44

Coronavirus-induced autoimmunity

Salle, V. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108694 · Cited by 44

COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart

Pesce, M., Agostoni, P., Bøtker, H. E., Brundel, B. J. J. M., Davidson, S. M., Caterina, R. D., Ferdinandy, P., Girão, H., Gyöngyösi, M., Hulot, J., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab201 · Cited by 43

Circulating multimeric immune complexes contribute to immunopathology in COVID-19

Ankerhold, J., Giese, S., Kolb, P., Maul‐Pavicic, A., Voll, R. E., Göppert, N., Ciminski, K., Kreutz, C., Lother, A., Salzer, U., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32867-z · Cited by 46

Concomitant brain arterial and venous thrombosis in a COVID‐19 patient

Malentacchi, M., Gned, D., Angelino, V., Demichelis, S., Perboni, A., Veltri, A., Bertolotto, A., & Capobianco, M. A. N. (2020) · European Journal of Neurology · doi:10.1111/ene.14380 · Cited by 45

Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis

Doo, F. X., Kassim, G., Lefton, D. R., Patterson, S., Pham, H., & Belani, P. B. (2020) · Clinical Imaging · doi:10.1016/j.clinimag.2020.07.007 · Cited by 43

Early mortality benefit with COVID‐19 convalescent plasma: a matched control study

Shenoy, A. G., Hettinger, A. Z., Fernandez, S. J., Blumenthal, J., & Báez, V. (2021) · British Journal of Haematology · doi:10.1111/bjh.17272 · Cited by 42

Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement

Mohkhedkar, M., Venigalla, S. S. K., & Vani, J. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.06.021 · Cited by 46

Anaesthesia and intensive care in obstetrics during the COVID-19 pandemic

Morau, E., Bouvet, L., Keïta, H., Vial, F., Bonnet, M., Bonnin, M., Gouez, A. L., CHASSARD, D., Mercier, F. J., Benhamou, D., et al. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2020.05.006 · Cited by 43

Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions

Minno, M. N. D. D., Calcaterra, I. L., Lupoli, R., Storino, A., Spedicato, G. A., Maniscalco, M., Minno, A. D., & Ambrosino, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072244 · Cited by 43

Surveillance Study of Acute Neurological Manifestations among 439 Egyptian Patients with COVID-19 in Assiut and Aswan University Hospitals

Khedr, E. M., Elfetoh, N. A., Daef, E., Hassan, H. M., Amin, M. T., Soliman, R. K., Attia, A. M., Zarzour, A. A., Zain, M., Hussein, A. A. R. M., et al. (2021) · Neuroepidemiology · doi:10.1159/000513647 · Cited by 44

Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications

Stasi, A., Franzin, R., Fiorentino, M., Squiccimarro, E., Castellano, G., & Gesualdo, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115980 · Cited by 44

Secuelas médicas de la COVID-19

Peramo-Álvarez, F. P., Zúñiga, M. Á. L., & López‐Ruz, M. Á. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.04.023 · Cited by 55

Pathophysiology of Antiphospholipid Syndrome

Green, D. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1701-2809 · Cited by 50

A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies

Li, C., Noreen, S., Zhang, L., Saeed, M., Wu, P., Ijaz, M., Dai, D., Maqbool, I., Madni, A., Akram, F., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112550 · Cited by 43

COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System

Kasal, D. A. B., Lorenzo, A. D., & Tibiriçá, E. V. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.08.010 · Cited by 41

Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease

Huynh, T., Wang, H., & Luan, B. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp03867a · Cited by 42

Hyperthrombotic Milieu in COVID-19 Patients

Kamel, M. H., Yin, W., Zavaro, C., Francis, J. M., & Chitalia, V. C. (2020) · Cells · doi:10.3390/cells9112392 · Cited by 42

A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection

Ghosh, R., De, K., Roy, D., Mandal, A., Biswas, S., Biswas, S., Sengupta, S., Naga, D., Ghosh, M., & Benito‐León, J. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577439 · Cited by 42

Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature

Stoian, A., Stoian, M., Bajkó, Z., Maier, S., Andone, S. R., Cioflinc, R. A., Moțățăianu, A., Bărcuţean, L., & Bălașa, R. (2022) · Biomedicines · doi:10.3390/biomedicines10040774 · Cited by 42

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity

Nasonov, E. L., Beketova, T. V., Reshetnyak, T. M., Lila, A. M., Ananieva, L., Lisitsyna, T. A., & Soloviev, S. K. (2020) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2020-353-367 · Cited by 44

Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19

Omarjee, L., Perrot, F., Meilhac, O., Mahé, G., Bousquet, G., & Janin, A. (2020) · Aging · doi:10.18632/aging.202422 · Cited by 43

Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature

Favaloro, E. J., Henry, B. M., & Lippi, G. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1729856 · Cited by 43

Bone marrow involvement in the non-Hodgkin's lymphomata.

Rosenberg, S. A. (1975) · Europe PMC (PubMed Central) · Cited by 42

Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

Delshad, M., Safaroghli‐Azar, A., Pourbagheri‐Sigaroodi, A., Poopak, B., Shokouhi, S., & Bashash, D. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107995 · Cited by 43

COVID-19-associated central retinal vein occlusion treated with oral aspirin

Venkatesh, R., Reddy, N. G., Agrawal, S., & Pereira, A. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-242987 · Cited by 41

A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors

Nicolson, P. L. R., Welsh, J. D., Chauhan, A., Thomas, M. R., Kahn, M. L., & Watson, S. P. (2020) · Platelets · doi:10.1080/09537104.2020.1775189 · Cited by 41

COVID-19 Presenting as Acute Limb Ischaemia

Kaur, P., Posimreddy, S., Singh, B., Qaqa, F., Habib, H. A., Maroules, M., & Shamoon, F. E. (2020) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2020_001724 · Cited by 40

Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era

Shakibajahromi, B., Borhani‐Haghighi, A., Haseli, S., & Mowla, A. (2020) · eNeurologicalSci · doi:10.1016/j.ensci.2020.100256 · Cited by 40

Apical Takotsubo Cardiomyopathy in a COVID-19 Patient Presenting with Stroke: A Case Report and Pathophysiologic Insights

Kariyanna, P. T., Chandrakumar, H. P., Jayarangaiah, A., Khan, A. H., Vulkanov, V., Ashamalla, M., Salifu, M. O., & McFarlane, S. I. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-8-10-8 · Cited by 40

Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients

Hoechter, D. J., Becker-Pennrich, A., Langrehr, J., Bruegel, M., Zwißler, B., Schaefer, S., Spannagl, M., Hinske, L. C., & Zöller, M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.08.030 · Cited by 40

Cerebrospinal fluid confirmed COVID-19-associated encephalitis treated successfully

Kamal, Y. M., Abdelmajid, Y., & Madani, A. A. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-237378 · Cited by 39

COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?

Hasbani, G. E., Taher, A. T., Jawad, A. S., & Uthman, I. W. (2020) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/1179544120978667 · Cited by 40

Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes

Pinney, S., Giustino, G., Halperin, J. L., Mechanick, J. I., Neibart, E., Olin, J. W., Rosenson, R. S., & Fuster, V. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.058 · Cited by 41

Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?

Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D. J., Li, S.-Y., Li, Y., & He, Y.-W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1859-y · Cited by 41

Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial

Önal, H., Arslan, B., Ergun, N. Ü., Topuz, H. Ş., Semerci, S. Y., KURNAZ, M. E., Yulet Miray, M. O. L. U., Bozkurt, M. A., Suner, N., & Kocataş, A. (2021) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2104-16 · Cited by 40

A comprehensive review of vascular complications in COVID-19

Acharya, Y., Alameer, A., Calpin, G. G., Alkhattab, M., & Sultan, S. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02593-2 · Cited by 39

Intravenous Immunoglobulin (IVIG) Significantly Reduces Respiratory Morbidity in COVID-19 Pneumonia: A Prospective Randomized TrialPreprint

Sakoulas, G., Geriak, M., Kullar, R., Greenwood, K. L., Habib, M., Vyas, A., Ghafourian, M., Dintyala, V. N. K., & Haddad, F. A. (2020) · medRxiv · doi:10.1101/2020.07.20.20157891 · Cited by 40

Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review

Nobari, N. N., & Goodarzi, A. (2020) · Dermatologic Therapy · doi:10.1111/dth.13867 · Cited by 39

Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients

Colafrancesco, S., Scrivo, R., Barbati, C., Conti, F., & Priori, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01439 · Cited by 38

On the genetics and immunopathogenesis of COVID-19

Jacob, C. O. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108591 · Cited by 39

Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review

Ehaideb, S. N., Abdullah, M. L., Abuyassin, B., & Bouchama, A. (2020) · Critical Care · doi:10.1186/s13054-020-03304-8 · Cited by 39

Thrombophilia Testing After Ischemic Stroke

Omran, S. S., Hartman, A., Zakai, N. A., & Navi, B. B. (2021) · Stroke · doi:10.1161/strokeaha.120.032360 · Cited by 44

Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

Foret, T., Dufrost, V., du Mont, L. S., Costa, P., Lefèvre, B., Lacolley, P. J., Regnault, V., Zuily, S., & Wahl, D. G. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01029-3 · Cited by 40

COVID‐19 and coagulopathy

Sarkar, M. S., Madabhavi, I., Quy, P. N., & Govindagoudar, M. B. (2021) · The Clinical Respiratory Journal · doi:10.1111/crj.13438 · Cited by 41

Neurological toll of COVID-19

Bhola, S., Trisal, J., Thakur, V., Kaur, P., Kulshrestha, S., Bhatia, S. K., & Kumar, P. (2022) · Neurological Sciences · doi:10.1007/s10072-022-05875-6 · Cited by 42

Renal infarct in a COVID-19–positive kidney–pancreas transplant recipient

Xu, J. J., Samaha, D., Mondhe, S., Massicotte‐Azarniouch, D., Knoll, G. A., & Ruzicka, M. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16089 · Cited by 39

Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report

Faqihi, F. A., Alharthy, A. M., Alshaya, R. A., Papanikolaou, J., Kutsogiannis, D. J., Brindley, P. G., & Karakitsos, D. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01665-0 · Cited by 41

Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure

Rando, H. M., MacLean, A. L., Lee, A. J., Lordan, R., Ray, S., Bansal, V., Skelly, A. N., Sell, E., Dziak, J. J., Shinholster, L., et al. (2021) · mSystems · doi:10.1128/msystems.00095-21 · Cited by 42

Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage

Kirtipal, N., Kumar, S., Dubey, S. K., Dwivedi, V. D., Babu, K. G., Malý, P., & Bharadwaj, S. (2022) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2022.105254 · Cited by 44

Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research

Levine, A. J., Sacktor, N. C., & Becker, J. T. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00897-2 · Cited by 39

Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic

Almeida, M. Q., & Mendonca, B. B. (2020) · Clinics · doi:10.6061/clinics/2020/e2022 · Cited by 38

Coronaviruses and Central Nervous System Manifestations

Khateb, M., Bosak, N., & Muqary, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00715 · Cited by 39

Engineering photonics solutions for COVID-19

Soler, M., Scholtz, A., Zeto, R., & Armani, A. M. (2020) · APL Photonics · doi:10.1063/5.0021270 · Cited by 41

Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis

Prasitlumkum, N., Chokesuwattanaskul, R., Thongprayoon, C., Bathini, T. J., Vallabhajosyula, S., & Cheungpasitporn, W. (2020) · Diseases · doi:10.3390/diseases8040040 · Cited by 38

Machine Learning Applied to Clinical Laboratory Data in Spain for COVID-19 Outcome Prediction: Model Development and Validation

Domínguez-Olmedo, J. L., Gragera-Martínez, Á., Vázquez, J. M., & Pachón, V. (2021) · Journal of Medical Internet Research · doi:10.2196/26211 · Cited by 38

Lupus Anticoagulant Single Positivity During the Acute Phase of COVID‐19 Is Not Associated With Venous Thromboembolism or In‐Hospital Mortality

Gendron, N., Dragon‐Durey, M., Chocron, R., Darnige, L., Jourdi, G., Philippe, A., Chenevier‐Gobeaux, C., Hadjadj, J., Duchemin, J., Khider, L., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41777 · Cited by 39

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

Emmenegger, M., Kumar, S. S., Emmenegger, V., Malinauskas, T., Buettner, T. L., Rose, L., Schierack, P., Sprinzl, M. F., Sommer, C., Lackner, K. J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010118 · Cited by 36

Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment

Adamczak, M., Surma, S., & Więcek, A. (2022) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/143542 · Cited by 38

SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination

Rivera, E. G., Patnaik, A., Salvemini, J. N., Jain, S., Lee, K., Lozeau, D. F., & Yao, Q. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109027 · Cited by 38

Portal vein thrombosis in a patient with COVID-19

Franco‐Moreno, A., Piniella-Ruiz, E., Montoya-Adárraga, J., Ballano-Franco, C., Alvarez-Miguel, F., Peinado-Martinez, C., Landete, E., Saez-Vaquero, T., Ulla‐Anés, M., & Torres‐Macho, J. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.019 · Cited by 39

Lung Injury in COVID-19─An Emerging Hypothesis

Alharthy, A. M., Faqihi, F. A., Memish, Z. A., & Karakitsos, D. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00422 · Cited by 38

Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection

Cavalli, E., Petralia, M. C., Basile, M. S., Bramanti, A., Bramanti, P., Nicoletti, F., Spandidos, D. A., Shoenfeld, Y., & Fagone, P. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4702 · Cited by 37

Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications

Kho, J., Ioannou, A., den Abbeele, K. V., Mandal, A. K. J., & Missouris, C. G. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.07.054 · Cited by 37

Coronavirus 2019, Microthromboses, and Platelet Activating Factor

Theoharides, T. C., Antonopoulou, S., & Demopoulos, C. A. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.08.006 · Cited by 36

Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy

Umemura, Y., Yamakawa, K., Kiguchi, T., Nishida, T., Kawada, M., & Fujimi, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092875 · Cited by 37

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies

Cristiano, A., Fortunati, V., Cherubini, F., Bernardini, S., & Nuccetelli, M. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05580-3 · Cited by 37

Incidence, Characteristics and Outcomes of Large Vessel Stroke in COVID-19 Cohort: An International Multicenter Study

Khandelwal, P., Al‐Mufti, F., Tiwari, A., Singla, A., Dmytriw, A. A., Piano, M., Quilici, L., Pero, G., Renieri, L., Limbucci, N., et al. (2021) · Neurosurgery · doi:10.1093/neuros/nyab111 · Cited by 38

How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C

Sharathkumar, A. A., Faustino, E. V. S., & Takemoto, C. M. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29049 · Cited by 37

COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on “Two-Path Unifying Theory” of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy

Chang, J. C. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s299357 · Cited by 37

Primary Adrenal Insufficiency Due to Bilateral Adrenal Infarction in COVID-19

Machado, I. F. R., Menezes, I. Q., de Figueiredo, S. R., Coelho, F. M. A., Terrabuio, D. R. B., Ramos, D. V., Fagundes, G. F. C., Maciel, A. A. W., Latronico, A. C., Fragoso, M. C. B. V., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab557 · Cited by 39

Ischemic Stroke in the Young

Berkman, S. A., & Song, S. S. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211002274 · Cited by 38

Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations

Rodríguez‐Pardo, J., Fuentes, B., de Leciñana, M. A., Campollo, J., Castaño, P. C., Ruiz, J. C., Herrero, J. E., Leal, R. G., Núñez, A. G., Cerezo, J. F. G., et al. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.04.007 · Cited by 36

Ischaemic stroke in the time of coronavirus disease 2019

Meza, H. T., Gil, Á. L., Saldaña, A. S., Yus, C., Baron, B., Mur, D. S., Moreno, J. M., & Aragón, G. D. S. Y. M. D. P. D. A. A. I. E. (2020) · European Journal of Neurology · doi:10.1111/ene.14327 · Cited by 36

COVID-19 and dermatology

Gül, Ü. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2005-182 · Cited by 36

COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers

Katz, J. M., Libman, R., WANG, J. J., Filippi, C. G., Sanelli, P. C., Zlochower, A. B., Gribko, M., Pacia, S. V., Kuzniecky, R., Najjar, S., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6920 · Cited by 36

Leveraging the Electronic Health Record to Address the COVID-19 Pandemic

Satterfield, B. A., Dikilitas, O., & Kullo, I. J. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.04.008 · Cited by 42

Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection

Savelieff, M. G., Feldman, E. L., & Stino, A. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105715 · Cited by 37

ANTIPHOSPHOLIPID-LIKE SYNDROME INDUCED BY COVID19: A CASE REPORT STUDY

Marinkovic, S. P., Anastasovski, A., & Todorovska, L. (2024) · Journal of Morphological Sciences · doi:10.55302/jms2471171pm

The changes of Coagulation State in Patients Contracted with SARS-COV-19

Nosrati, A. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2020.129354.2427 · Cited by 1

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy.

Nosrati, A., Torabizadeh, Z., Kheirkhah, D., Larijani, L. V., Alizade-Navaei, R., Mobini, M., Aliyali, M., Abedi, S., & Mehravaran, H. (2022) · PubMed Central · Cited by 2